The research showed that the AFP-L2 levels of gravidas screening for trisomy 21 and 18 fetuses in second trimester were higher than in the control subjects (1.48 and 1.46 vs. 0.83 MoM, respectively) (P < 0.001). This evidence concerns the gene AFP and trisomy 21.